Effectiveness and safety of pembrolizumab for the treatment of Japanese patients with microsatellite instability-high tumors excluding colorectal cancer: a post-marketing surveillance
This study confirmed the real-world effectiveness and safety of pembrolizumab monotherapy in patients with MSI-H solid tumors except colorectal cancer in Japan.
Authors
- Daisuke Aoki (ORCID: https://orcid.org/0000-0002-9596-8326)
- Masahiro Hamada
- K. Muro
- Shinichiroh Maekawa
- Yuichiro Ito
- Masahiko Ozaki
- M. Izawa
- Mai Yamauchi
Institutions
- MSD K.K. (Japan) (JP)
- Aichi Cancer Center (JP)
- Sanno Medical Center (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-05-18
- DOI
- https://doi.org/10.1093/jjco/hyaf064
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Meso Scale Diagnostics
- MSD K.K.